Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.44 AUD | -1.12% | -4.35% | -22.81% |
May. 15 | Transcript : Imricor Medical Systems, Inc. - Shareholder/Analyst Call | |
May. 09 | Imricor Medical Systems' VISABL-AFL Trial Receives Final Clearance from Swissmedic | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.81% | 59.86M | |
+10.03% | 223B | |
+13.59% | 195B | |
+20.01% | 144B | |
+30.83% | 111B | |
+2.28% | 65.01B | |
+15.38% | 53.02B | |
+3.64% | 50.45B | |
+8.37% | 44.15B | |
+3.27% | 36.45B |
- Stock Market
- Equities
- IMR Stock
- News Imricor Medical Systems, Inc.
- Imricor Medical Systems Gains Approval for Clinical Trial at Cardiovascular Institute of South Paris; Shares Up 7%